CYP19A1 and neoplasm: While recent studies have demonstrated that histone deacetylase inhibitors such as panobinostat abrogated the growth of aromatase inhibitor-resistant cells in vitro and in vivo, caused cell cycle G2/M arrest, and induced apoptosis it failed to cause tumor regression [3].